Orteronel Misses Goal in Metastatic Hormone-Sensitive Prostate Cancer
Significant improvement seen in progression-free survival, but not overall survival, with addition of orteronel to androgen deprivation therapy
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Advanced Prostate Cancer Center of Excellence
Visit our Advanced Prostate Cancer Center of Excellence for additional, in-depth coverage.